Recombinant HIV1 gp120 + gp41 protein (ab68127)

Overview

Description

  • NatureRecombinant
  • SourceEscherichia coli
  • Amino Acid Sequence
    • Additional sequence informationHIV-1 gp41-gp120 is a non-glycosylated polypeptide chain fused to 6xHis Tag

Specifications

Our Abpromise guarantee covers the use of ab68127 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Biological activityab68127 is immunoreactive with all sera of HIV1 and HIV-type O infected individuals and with 60-80% of HIV2 infected individuals.
  • Applications

    Western blot

    ELISA

    SDS-PAGE

  • Purity> 95 % SDS-PAGE.

  • FormLiquid
  • Additional notes

    ab68127 is Immunoreactive with all sera of HIV-I infected individuals.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    pH: 8.00
    Preservative: 1.02% Imidazole
    Constituents: 0.87% Sodium chloride, 50% Glycerol, 0.41% Sodium phosphate

General Info

  • Alternative names
    • Glycoprotein 120
    • Glycoprotein 41
    • HIV1 gp120
    • HIV1 gp41
    • SU
    • TM
    see all
  • Relevancegp41/120 is the major HIV protein associated with the HIV envelope. It functions as the viral antireceptor or attachment protein. gp41 (or TM) traverses the envelope, whereas gp120 is present on the outer surface and is noncovalently attached to gp41. The precursor of gp120/41 (gp160) is synthesized in the endoplasmic reticulum and is transported via the golgi body to the cell surface. Upon activation of the envelope glycoprotein (gp120/41) by cellular receptors, gp41 undergoes conformational changes that mediate fusion of the viral and cellular membranes.

References for Recombinant HIV1 gp120 + gp41 protein (ab68127)

ab68127 has not yet been referenced specifically in any publications.

Product Wall



ab68127 corresponds to Strain MN



I am still awaiting strain information regarding ab68872. I will forward this to you as soon as it is available.

Thank you for contacting us. Theoretically your outline makes sense. However, we have not tested the products this way and cannot guarantee that the binding sites of the antibodies will not interfere with each other. I hope this is helpful. Please le m...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"